LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/IBM’s Watson Supercomputer Improves Clinical Studies at Mayo
Company News

IBM’s Watson Supercomputer Improves Clinical Studies at Mayo

October 19, 2014 1 min read Premium comments

Advertisement

IBM’s Watson Supercomputer Improves Clinical Studies at Mayo
IBM Watson Computer / Source: Wikimedia Commons and Clockready
Secondary

At any given time, patients at the Mayo Clinic, headquartered in Rochester, Minnesota, are participating in 8, 000 clinical trials. Beginning next year the process of matching patients to appropriate trials—currently done manually—will be taken over by Watson, IBM.s supercomputer. The plan is for Watson to take over much of the work of comparing a patient’s characteristics to the inclusion/exclusion criteria for recruiting participants in clinical trials.

Mayo Clinic’s goal is to double the proportion of patients that take part in clinical research and bring the number up to 10%, according to Nick Paul Taylor, writing in FierceBiotechIT. “Using Watson’s cognitive computing capabilities, Mayo Clinic can consistently offer more cutting-edge medical options to patients and conclude trials faster, ” IBM SVP Mike Rhodin said in a statement.

Taylor wrote that IBM is designing a version of Watson specifically for the needs of Mayo Clinic. The process involves adding details of all the clinical trials underway at Mayo Clinic—plus those on ClinicalTrials.gov—to Watson’s library. Watson is also being trained to find matches between the trials in these resources and health records of patients at Mayo Clinic.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy